NRSN

NeuroSense Therapeutics Ltd. Ordinary Shares

0.95

USD

NRSN Earnings Reports

Positive Surprise Ratio

NRSN beat 5 of 8 last estimates.

63%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

NeuroSense Therapeutics Ltd. Ordinary Shares earnings per share and revenue

On Jan 28, 2026, NRSN reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.05 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were NeuroSense Therapeutics Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, NeuroSense Therapeutics Ltd. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to NeuroSense Therapeutics Ltd. Ordinary Shares's Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is NeuroSense Therapeutics Ltd. Ordinary Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for NeuroSense Therapeutics Ltd. Ordinary Shares's next earnings report?

Based on -- analysts, NeuroSense Therapeutics Ltd. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.